Arrow-right Camera
The Spokesman-Review Newspaper
Spokane, Washington  Est. May 19, 1883

‘Patent trolls’ target of new bill

Associated Press

WASHINGTON — The high-tech industry calls them “patent trolls” — people who get patents for products they never plan to make, just so they can sue for infringement if a company does turn out something similar.

That is how critics describe the inventor from Great Falls, Va., whom Internet giant eBay wants to take to the Supreme Court over online selling techniques he patented.

Now Congress, urged on by a coalition of high-tech companies that includes eBay, wants protection against such people.

“I think patent trolls are abusing the system,” said Rep. Lamar Smith, R-Texas, who wrote the bill.

The first major changes to patent law since 1999 are running into opposition from drug makers, fearful an overhaul could stifle their ability to bring innovative products to the market.

A bill introduced in the House on Wednesday would make it harder for patent-holders to get court orders to stop the sale of products that potentially infringe on their patents. Challenging a patent would become easier.

Also, the legislation would commit the U.S. to international standards on patent registration: The patent goes to the inventor who files first.

Smith, chairman of the House Judiciary subcommittee on intellectual property, co-sponsored the bill with the committee’s top Democrat, Rep. Howard Berman, D-Calif. A hearing was set for Thursday.

The Information Technology Industry Council, which represents eBay and other high-tech companies, says patent lawsuits in federal court doubled from 1,200 to 2,400 annually from 1998 to 2001.

“The broken patent system right now, and the rise in lawsuits, has unfortunately discouraged our companies from innovating, and patent trolls are gaming the system,” said Josh Ackil, the group’s vice president of government relations.

The boom of the 1990s led to a rush to patent new kinds of technology, some of which was poorly understood at the time, the industry says.

Unlike high-tech businesses, pharmaceutical companies do not have the same problems with “patent trolls” because drug formulas generally are more difficult to develop than computer technology.